With a price-to-sales (or "P/S") ratio of 5.7x Moderna, Inc. (NASDAQ:MRNA) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States ...
Source LinkWith a price-to-sales (or "P/S") ratio of 5.7x Moderna, Inc. (NASDAQ:MRNA) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States ...
Source Link
Comments